1. Home
  2. FUTU vs BIO Comparison

FUTU vs BIO Comparison

Compare FUTU & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Futu Holdings Limited

FUTU

Futu Holdings Limited

HOLD

Current Price

$162.86

Market Cap

23.1B

Sector

Finance

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$301.36

Market Cap

8.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUTU
BIO
Founded
2011
1952
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
23.1B
8.2B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
FUTU
BIO
Price
$162.86
$301.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$208.60
$358.50
AVG Volume (30 Days)
1.3M
165.1K
Earning Date
11-18-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
119.17
N/A
EPS
8.95
N/A
Revenue
$2,442,834,991.00
$2,557,500,000.00
Revenue This Year
$87.24
$1.77
Revenue Next Year
$13.85
$2.30
P/E Ratio
$17.92
N/A
Revenue Growth
87.15
N/A
52 Week Low
$70.60
$211.43
52 Week High
$202.53
$373.69

Technical Indicators

Market Signals
Indicator
FUTU
BIO
Relative Strength Index (RSI) 41.24 39.83
Support Level $159.00 $298.02
Resistance Level $166.67 $319.50
Average True Range (ATR) 5.94 8.35
MACD -0.77 -2.12
Stochastic Oscillator 20.62 10.28

Price Performance

Historical Comparison
FUTU
BIO

About FUTU Futu Holdings Limited

Futu Holdings Ltd is an online broker providing one-stop online investing services. The company provides its services through its digital platform Futu NiuNiu, which includes market data, trading service, and news feed of Hong Kong, Mainland China, Singapore, and the United States equity markets. It generates its revenue in the form of brokerage commission and handling charge services, and interest income.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: